Results

Total Results: 1,541 records

Showing results for "months".

161. Research Protocol: Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
     January 30, 2020 - The disposition of comments for systematic reviews and technical briefs will be published 3 months after … Daptacel Infanrix 6 weeks through 6 years; routine Hepatitis A (HepA) Havrix Vaqta 12 months … FluMist Quadrivalent 2 through 49 years; IIV or LAIV Measles, mumps, rubella (MMR) M-M-R II 12 months … through 55 years (Menactra); routine 2 months through 55 years (Menveo); routine Meningococcal … immunity Meningococcal (MenACWY- D, Men-ACWY-CRM) Menactra (MenACWY-D) Menveo (MenACWY-CRM) 9 months

162. Erythropoiesis-Stimulating-Agents-Utilization Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/erythropoiesis-stimulating-agents-utilization_research.pdf
     February 01, 2011 - Trends in the utilization of erythropoiesis-stimulating agents among Medicare beneficiaries with kidney disease Erythropoietins Data Points #4 The findings described herein were presented by Thomas MaCurdy, Ph.D., at the Medicare Evidence Development & Coverage Advisory Committee meeting held on March 24, 2010,…

163. Evidence Summary: Management of Colonic Diverticulitis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-233-diverticulitis-evidence-summary.pdf
     October 01, 2020 - episode of acute diverticulitis o There is low SoE that patients with recent diverticulitis (within 6-12 months … o Colonoscopies conducted within 1.5 to 12 months after acute diverticulitis rarely have complications … colonoscopy soon after an episode of acute diverticulitis (within about 2-12 4 months

164. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-2005_executive.pdf
     January 01, 2005 - laparoscopic fundoplication in patients with GERD documented by pH or endoscopy, the longest followup was 8 months … For maintenance medical treatment of 6 months to 1 year, PPIs taken at a standard dose (as suggested … sham, Stretta™ was more effective in improving symptoms of reflux and improving quality of life at 6 months … necrosis); there were no deaths in the surgical group; 4.5% developed dysphagia that persisted for > 3 months

165. Interventions Targeting Sensory Challenges in Children With Autism Spectrum Disorders - An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/asd-interventions-disposition.pdf
     May 26, 2017 - the authors’ responses to the comments are posted for public viewing on the Web site approximately 3 months … ; > 6 months; ≥ 12 months; or > 12 months? … KQs define short term as ≤ 6 months and longer-term as >6 months, but the abstract describes short term … as < 12 months. … We have clarified the time frame to reflect ≤ 6 months as short term and greater than 6 months as long

166. Psoriatic Arthritis Surveillance Assesment_CER 54_Low (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_surveillance.pdf
     March 01, 2013 - 10 mg/kg greatest improvement.8 The Go-REVEAL trial reported that change in HAQ scores at 24 months … 170 PsA patients with target lesion (TL) at least 2 cm who had previously taken DMARDs 6 months … adverse events Kingsley, 201215 RCT MIPA MTX vs placebo 2003-2008 221 PsA patients in UK 6 months … patients began receiving golimumab. 2006-2007 405 PsA patients in US, Canada, and Europe 12 months … 20114 Cohort NA Any anti-TNF or non- biologic DMARD 1998-2007 3,113 PsO- PsA - As patients 12 months

167. Disclosure Policy and Form (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-ki-tep-confidentiality-form.pdf
     August 01, 2020 - peer and public review comments by the authors will be posted on the Effective Health Care Web site 3 months … peer and public review comments by the authors will be posted on the Effective Health Care Web site 3 months

168. Medicare-Medication-Use Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-medication-use_research.pdf
     April 01, 2014 - All Part D indicates continuous Part D coverage during the reference year for all months of Medicare … eligibility (i.e., months where the benefi- ciary was alive and covered by Medicare). … We identified the number of coverage months using the monthly Part D plan contract identifier. … The population of 17.6 million Medicare beneficiaries who had Part D coverage for all months of Medicare … Slightly over 50 percent of Medicare A and B FFS beneficiaries had Part D cover- age for all months

169. Comparative Effectiveness and Safety of New Therapies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-glucose-control_research.pdf
     July 01, 2010 - Fifty-three percent of the early users (first 3 months) were female. …  Have a claim with a code for diabetes mellitus (ICD-9-CM 250.xx) at least twice12,13  Have 12 months … supply, the patient would have an indicator signifying that he had the medication in the subsequent two months … Discussion The early users of this new drug (in the first six months since approval) were largely … In summary, exenatide became widely-used in the United States in the months following its approval.

170. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - depending on expert comments received on interventions issued for comment during the preceding 6 months … The difference between Mobi-C and ACDF success rates at 6, 3 12, and 18 months were +49.4%, … , respectively  Improvements in 50-foot walk pain of 26% and 17% from baseline at 6 and 12 months … , respectively  Improvements in WOMAC scores of 20% and 8% from baseline at 6 and 12 months, … and 12 months, respectively.36 Manufacturer and regulatory status: FDA categorizes therapeutic stem

171. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
     January 01, 2015 - depending on expert comments received on interventions issued for comment during the preceding 6 months … This test indicates the patient’s average blood sugar level for the previous 2 or 3 months, and an … After 6 months of treatment, the hypoglycemic event rates in the pump-only group decreased from 28 … The adjusted incidence rate per 100 patient-months was 34.2 (95% confidence interval [CI], 22.0 to … Medtronic continuous glucose monitoring & MiniMed 530G: two months later. [internet].

172. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
     January 01, 2010 - e.g. motor, sensory, medical, mood/anxiety, irritability, and hyperactivity) in the short term (≤6 months … outcomes to be studied as follows: short-term outcomes will be considered as those that occur ≤ 6 months … and long-term outcomes as those that occur >6 months. … studies in which the mean age + standard deviation of the participants does not exceed 12 years, 11 months … the peer review comments are documented and will, for CERs and Technical briefs, be published three months

173. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
     December 09, 2009 - e.g. motor, sensory, medical, mood/anxiety, irritability, and hyperactivity) in the short term (≤6 months … outcomes to be studied as follows: short-term outcomes will be considered as those that occur ≤ 6 months … and long-term outcomes as those that occur >6 months. … studies in which the mean age + standard deviation of the participants does not exceed 12 years, 11 months … the peer review comments are documented and will, for CERs and Technical briefs, be published three months

174. Protocol Amendment - Safety of Vaccines 030413 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccines-safety-protocol-130325.pdf
     September 18, 2012 - and older Hepatitis B Birth and older Hib (Haemophilus influenzae type b) 6 weeks – 59 months HPV … (human papillomavirus) 9 years – 26 years Influenza (inactivated) 6 months and older Influenza (live … ) 6 weeks – 18 years Pneumococcal polysaccharide vaccine 2 years and older Rotavirus 6 weeks – 8 months … Tdap (tetanus, diphtheria, and acellular pertussis) 7 years and older Varicella 12 months and … National, state, and local area vaccination coverage among children aged 19–35 months—United States,

175. Clinical-Care-Rapid-Review-Appendix-C (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/clinical-care-rapid-review-appendix-c.xlsx
     January 01, 2018 - , community hospitals Preimplementation, Cumulative rate of closure at 36 months Pre-implementation, … , Cumulative rate of closure at 36 months Pre-implementation, at 36 months NR Events: AMC1: 67% AMC2 … , AMCs Post-implementation, Cumulative rate of closure at 36 months Post-implementation, at 36 months … hospitals, AMCs Post-implementation, Cumulative rate of closure at 36 months Post-implementation, at … , at 36 months NR Events: 62% NA NA NA Evidence Table C-13 Evidence Table C-13.

176. Tonsillectomy for Obstructive Sleep-Disordered Breathing or Recurrent Throat Infection in Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/tonsillectomy_executive.pdf
     January 01, 2017 - Benefits seemed durable, with followup ranging from 6 months to 4 years. … Down syndrome or mucopolysaccharidoses and reported no significant group differences in AHI at 12 months … In the longer term (>12 months) we found no difference between groups in reduction in streptococcal … found no differences between groups in missed school/work or quality of life in the long term (>12 months … We found no difference in effects on long-term (>12 months) persistence of OSDB symptoms, quality of

177. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
     March 01, 2022 - Overall, in patients with chronic (mainly neuropathic) pain with short-term treatment (4 weeks to <6 months … : Benefits of cannabinoids for chronic pain compared with placebo in the short term (4 weeks to <6 months … Background Chronic pain is defined as pain lasting longer than 3 to 6 months or past normal time for … The findings are applicable to short-term treatment (4 weeks to <6 months) in patients with chronic … , 6 to 12 months, and ≥12 months).4-8 Meta-analyses were conducted to summarize data and obtain more

178. Future Research Needs for Noncyclic Chronic Pelvic Pain Therapies for Women (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/pelvic-pain-therapies-future_research.pdf
     January 01, 2015 - of Obstetricians and Gynecologists defines chronic pelvic pain as “noncyclical pain of at least 6 months … as self reported · No antimicrobials for urinary tract infections in previous 3 months as self … as self reported · No urethritis for previous 3 months as self reported · No urethral dilatation … , cystometrogram, bladder cystoscopy with full anesthesia or bladder biopsy in previous 3 months as … Daily administration (TID) and by oral capsule, treatment given for 6 months.

179. Ebell_Presentation_REVISED_FINAL (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/use_of_handheld_ebell_presentation.pdf
     January 01, 2009 - year  and  clinical  choices:   • Reassure:  -­‐=3  points   • Monitor  every  4  months … :  4-­‐6  points   • Monitor  every  2  months:  7-­‐8  points   • Treat:  >8  

180. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
     May 01, 2022 - evidence, in patients with chronic (mainly neuropathic) pain with short-term treatment (4 weeks to <6 months … : Benefits of cannabinoids for chronic pain compared with placebo in the short term (4 weeks to <6 months … Background Chronic pain is defined as pain lasting longer than 3 to 6 months or past normal time for … , 6 to 12 months, and ≥12 months).4-8 Meta-analyses were conducted to summarize data and obtain more … Dizziness for comparable THC to CBD ratio versus placebo (short-term, 4 weeks to 6 months followup)